A novel EcoRII PCR-RFLP detecting genetic variation of goat <i>NF1-C2</i> gene and its association with milk yield (Brief Report)

Abstract. The transcription factor nuclear factor1-C2 (NF1-C2) mediates the action of prolactin in the mammary gland. Research on the molecular genetic mechanism of model system have indicated that the NF1-C2 gene plays an important role for the activation of several mammary gland specific genes (Nilsson et al. 2006). Moreover, the effects of prolactin on milk production traits have been reported in ruminant (Seriwatanachai et al. 2008). NF1-C2 may have a similar function in goat. To our knowledge polymorphisms of NF1-C2 gene have not been described in animals. Here a SNP of the caprine NF1-C2 was detected and a EcoRII PCR-RFLP was derived, that allowed to clearly detect NF1-C2 genotypes. Further investigation was conduct to evaluate the association between polymorphisms and milk yield at different lactation stages.

Subdiffusion of a sticky particle on a surface

Conventional diffusion (ΔR2(t))=2Dt gives way to subdiffusion (ΔR2(t))∼t(μ), 0<μ<1 when the waiting time distribution φ(τ) is nonintegrable. We have studied a model system, colloidal particles functionalized with DNA "sticky ends" diffusing on a complementary coated surface. We observe a crossover from subdiffusive to conventional behavior for (ΔR2(t)) and φ(τ) as temperature is increased near the particle-surface melting temperature consistent with a simple Gaussian distribution of sticky ends. Our results suggest that any system with randomness in its binding energy should exhibit subdiffusive behavior as it unbinds. This will strongly affect the kinetics of self-assembly.

The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats

The present study was the first report demonstrating that pulsed electromagnetic field (PEMF) could partially prevent bone strength and architecture deterioration and improve the impaired bone formation in streptozotocin-induced diabetic rats. The findings indicated that PEMF might become a potential additive method for inhibiting diabetic osteopenia or osteoporosis.

INTRODUCTION

Diabetes mellitus (DM) can cause various musculoskeletal abnormalities. Optimal therapeutic methods for diabetic bone complication are still lacking. It is essential to develop more effective and safe therapeutic methods for diabetic bone disorders. Pulsed electromagnetic field (PEMF) as an alternative noninvasive method has proven to be effective for treating fracture healing and osteoporosis in non-diabetic conditions. However, the issue about the therapeutic effects of PEMF on diabetic bone complication has not been previously investigated.

METHODS

We herein systematically evaluated the preventive effects of PEMF on diabetic bone loss in streptozotocin-treated rats. Two similar experiments were conducted. In each experiment, 16 diabetic and eight non-diabetic rats were equally assigned to the control, DM, and DM + PEMF group. DM + PEMF group was subjected to daily 8-h PEMF exposure for 8 weeks.

RESULTS

In experiment 1, three-point bending test suggested that PEMF improved the biomechanical quality of diabetic bone tissues, evidenced by increased maximum load, stiffness, and energy absorption. Microcomputed tomography analysis demonstrated that DM-induced bone architecture deterioration was partially reversed by PEMF, evidenced by increased Tb.N, Tb.Th, BV/TV, and Conn.D and reduced Tb.Sp and SMI. Serum OC analysis indicated that PEMF partially prevented DM-induced decrease in bone formation. In experiment 2, no significant difference in the bone resorption marker TRACP5b was observed. These biochemical findings were further supported by the dynamic bone histomorphometric parameters BFR/BS and Oc.N/BS.

CONCLUSIONS

The results demonstrated that PEMF could partially prevent DM-induced bone strength and architecture deterioration and improve the impaired bone formation. PEMF might become a potential additive method for inhibiting diabetic osteoporosis.